IMTX
Companies
NASDAQ
Immatics N.V.
Health Care
$5.44
-$1.67 (-23.49%)
Price Chart
Overview
About IMTX
Immatics NV is a biotechnology company that is engaged in the research and development of T-cell redirecting immunotherapies for the treatment of cancer patients. The company earns revenue through strategic collaboration agreements with third-party pharmaceutical and biotechnology companies.
Market Cap
$1.4B
Volume
5.5M
Avg. Volume
3.9M
P/E Ratio
-2.7613635
Dividend Yield
0.00%
Employees
362.0
Company Information
Risk & Correlation Analysis
Market Correlation
0.65
Low Correlation
Volatility
High (0.51)
Relative to market
Macro Factor Sensitivities
Interest Rates
Medium Sensitivity
Inflation
Medium Sensitivity
GDP Growth
Low Sensitivity
Liquidity
Low Sensitivity
Commodity Prices
Medium Sensitivity
Credit Quality
Medium Sensitivity
Portfolio Impact
Forecasts & Predictions
1-Month Target
$XXX.XX
+X.X% Potential
3-Month Target
$XXX.XX
+X.X% Potential
12-Month Target
$XXX.XX
+X.X% Potential
Technical Analysis
Based on technical indicators and chart patterns, IMTX shows...
AI Sentiment Analysis
Market sentiment analysis indicates...
Key Statistics
Market Cap$1.4B
Volume5.5M
P/E Ratio-2.76
Dividend Yield0.00%
Important Dates
Next Dividend
Next Earnings
March 27, 2025Related Securities
Pricing info last updated June 19, 2025 (after market close)Other info last updated April 2, 2025